A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer (Q39704674)

14 September 2017

A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer (English)

1 reference

14 September 2017

13

Li Jin

1 reference

14 September 2017

Shuyu Zhang

1

1 reference

14 September 2017

Juan Lu

2

1 reference

14 September 2017

Xueying Zhao

3

1 reference

14 September 2017

Wenting Wu

4

1 reference

14 September 2017

Huibo Wang

5

1 reference

14 September 2017

Jun Lu

6

1 reference

14 September 2017

Qihan Wu

7

1 reference

14 September 2017

Xin Chen

8

1 reference

14 September 2017

Weiwei Fan

9

1 reference

14 September 2017

Hongyan Chen

10

1 reference

14 September 2017

Feng Wang

11

1 reference

14 September 2017

Zhibin Hu

12

1 reference

14 September 2017

Qingyi Wei

14

1 reference

14 September 2017

Hongbing Shen

15

1 reference

14 September 2017

Wei Huang

16

1 reference

14 September 2017

Daru Lu

17

1 reference

14 September 2017

language of work or name

English

0 references

publication date

12 May 2010

1 reference

14 September 2017

1 reference

14 September 2017

31

1 reference

14 September 2017

7

1 reference

14 September 2017

1251-1258

1 reference

Global cancer statistics, 2002

14 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Genome maintenance mechanisms are critical for preventing cancer as well as other aging-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Chk1 and Chk2 kinases in checkpoint control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

21 January 2018

The Chk2 protein kinase

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Chk2 activates E2F-1 in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

A p53-dependent checkpoint pathway prevents rereplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

The breast cancer susceptibility allele CHEK2*1100delC promotes genomic instability in a knock-in mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

CHEK2 is a multiorgan cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Mutations in CHEK2 associated with prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Bisulfite genomic sequencing: systematic investigation of critical experimental parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Cigarette smoke is an endothelial stressor and leads to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Endogenous nitric oxide activation protects against cigarette smoking induced apoptosis in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Sp1 activates and inhibits transcription from separate elements in the proximal promoter of the human adenine nucleotide translocase 2 (ANT2) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

CHEK2 variant I157T may be associated with increased breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Chk2 down-regulation by promoter hypermethylation in human bulk gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ089

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGQ089

1 reference

14 September 2017

1 reference